ENDRA Life Sciences, Inc. (NDRA)
5.89
-0.02
(-0.25%)
USD |
NASDAQ |
Sep 09, 16:00
5.89
0.00 (0.00%)
After-Hours: 18:10
ENDRA Life Sciences EPS Diluted (Quarterly) : 0.1208 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1208 |
| March 31, 2026 | -1.093 |
| December 31, 2025 | -3.249 |
| September 30, 2025 | -2.097 |
| June 30, 2025 | -1.710 |
| March 31, 2025 | -1.859 |
| December 31, 2024 | -7.728 |
| September 30, 2024 | -333.82 |
| June 30, 2024 | -142.98 |
| March 31, 2024 | -449.58 |
| December 31, 2023 | -245.82 |
| September 30, 2023 | -706.20 |
| June 30, 2023 | -746.30 |
| March 31, 2023 | -1625.00 |
| December 31, 2022 | -1816.54 |
| September 30, 2022 | -1906.10 |
| June 30, 2022 | -2038.75 |
| March 31, 2022 | -2323.65 |
| December 31, 2021 | -2553.60 |
| September 30, 2021 | -2219.70 |
| June 30, 2021 | -2686.60 |
| Date | Value |
|---|---|
| March 31, 2021 | -2214.80 |
| December 31, 2020 | -2313.50 |
| September 30, 2020 | -5352.90 |
| June 30, 2020 | -6873.65 |
| March 31, 2020 | -10105.20 |
| December 31, 2019 | -41733.65 |
| September 30, 2019 | -16082.50 |
| June 30, 2019 | -11007.15 |
| March 31, 2019 | -12961.20 |
| December 31, 2018 | -11154.50 |
| September 30, 2018 | -24580.50 |
| June 30, 2018 | -16476.25 |
| March 31, 2018 | -25206.30 |
| December 31, 2017 | -20472.20 |
| September 30, 2017 | -8050.00 |
| June 30, 2017 | -20650.00 |
| March 31, 2017 | -6643.70 |
| December 31, 2016 | -6153.35 |
| September 30, 2016 | -8778.00 |
| December 31, 2015 | -4109.35 |
| September 30, 2015 | -4846.45 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Accuray, Inc. | -0.0154 |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | -0.3862 |
| ResMed, Inc. | 2.645 |
| Rockwell Medical, Inc. | -0.3352 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.1599M |
| Total Expenses (Quarterly) | -0.1599M |
| Enterprise Value | 3.746M |
| Earnings Yield | -107.3% |
| Normalized Earnings Yield | -103.48 |